Company
Beyond Barriers Therapeutics
Introducing BBT-101: a first-of-its-kind, intranasal therapy for concussions, designed to be fast, field-deployable, and effective.
Also known as Beyond Barriers Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Beyond Barriers Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Today, Beyond Barriers Therapeutics (BBT) is a clinical-stage biotechnology company developing BBT-101: the first-of-its-kind, intranasal therapeutic designed to mitigate the damaging secondary effects of mild traumatic brain injuries (mTBI) (also known as concussions) and moderate TBIs.
Products
- Other
- BBT-101
Loading relationship preview